Crown Bioscience
About
Crown Bioscience is a global contract research organization (CRO) that provides preclinical and translational research services to accelerate drug discovery and development in oncology and immuno-oncology. They offer a comprehensive suite of solutions including in vivo, in vitro, ex vivo, and in silico methods, advanced models, and biobanking services to biotech and pharmaceutical companies.
Key facts
At-a-glance profile data
- Website
- crownbio.com
- Headquarters
- San Diego, United States
- Founded
- 2006
- Total funding
- $262M (Acquisition)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 13 Nov 2025 | Acquisition | $204M | - |
| 25 Apr 2014 | Series D | $27M | Lilly Asia Ventures |
| 4 May 2011 | Series C | $29M | OrbiMed, The CID Group, CDIB Capital |
| 1 Jan 2007 | Early Stage VC | $3M | - |
Tech stack
Detected on crownbio.com, last scanned 9 Sept 2026. Run your own scan
- Analytics
- Google Analytics 4, Google Tag Manager, Segment, Hotjar, Meta Pixel
- Support
- Drift, HubSpot
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Crown Bioscience raised?
Crown Bioscience has raised a total of $262M in funding. The most recent round on record is Acquisition.